Medinet CoTSE:2370 45 Operating Margin % is -111.10% as of Mar. 2026. GuruFocus rates TSE:2370 with a GF Score™ of 45/100 and a GF Value™ of 円41.77 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 945 Biotechnology companies, Medinet Co ranks worse than 56.83% on this metric.
Operating Margin % is calculated as Operating Income divided by its Revenue. Medinet Co's Operating Income for the
three
months ended in Mar. 2026 was 円-258.7 Mil. Medinet Co's Revenue for the
three
months ended in Mar. 2026 was 円232.9 Mil. Therefore, Medinet Co's Operating Margin % for the quarter that ended in Mar. 2026 was -111.10%.
Warning Sign:
Medinet Co Ltd operating margin has been in a 5-year decline. The average rate of decline per year is -7.3%.
The historical rank and industry rank for Medinet Co's Operating Margin % or its related term are showing as below:
TSE:2370'
s Operating Margin % Range Over the Past 10 Years
Min: -283.39 Med: -168.3 Max: -88.05
Current: -161
TSE:2370's Operating Margin % is ranked worse than 56.83% of 945
companies
in the Biotechnology industry
Industry Median: -86.89
vs TSE:2370: -161.00
Medinet Co's 5-Year Average Operating Margin % Growth Rate was -7.30% per year.
Medinet Co's Operating Income for the
three
months ended in Mar. 2026 was 円-258.7 Mil.
Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 was 円-1,319.4 Mil.
Medinet Co (TSE:2370) Operating Margin % Explanation
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Medinet Co Operating Margin % Related Terms
Medinet Co Operating Margin % Historical Data
* Premium members only.
The historical data trend for Medinet Co's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:2370 vs VRTX, REGN, ALNY: Operating Margin % Comparison
For the Biotechnology subindustry, Medinet Co's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medinet Co Operating Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Medinet Co's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Medinet Co's Operating Margin % falls into.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Medinet Co's Operating Margin % for the fiscal year that ended in Sep. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medinet Co (TSE:2370) has a Operating Margin % of -111.10% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Medinet Co and its competitors. According to the industry distribution chart, Medinet Co ranks #537 out of 945 companies in the Biotechnology industry, placing it in the top 56.8%.
Is Medinet Co's Operating Margin % too high?
Medinet Co's current Operating Margin % is -111.10%. Based on the distribution chart, Medinet Co ranks #537 out of 945 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Medinet Co has a GF Score™ of 45/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Medinet Co's Operating Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Medinet Co ranks #537 out of 945 companies for Operating Margin %. This places Medinet Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Biotechnology company?
A good Operating Margin % depends on the Biotechnology industry context. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Medinet Co and its competitors. Medinet Co's current Operating Margin % is -111.10%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medinet Co stock overvalued right now?
Based on GuruFocus' analysis, Medinet Co (TSE:2370) is currently considered Possible Value Trap. The stock's GF Value™ is 円41.77, compared to a current price of 円24.00 — trading 42.5% below its estimated fair value. The current Operating Margin % is -111.10%. Medinet Co's overall GF Score™ is 45/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Medinet Co (TSE:2370), the current Operating Margin % is -111.10% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medinet Co (TSE:2370) Overvalued in 2026?
Based on GuruFocus' analysis, Medinet Co stock appears to be undervalued.
The current stock price of 円24.00 is trading 42.5% below its estimated GF Value™ of 円41.77.
GuruFocus considers Medinet Co to be Possible Value Trap.
Key valuation signals for TSE:2370:
Operating Margin %: -111.10%
GF Value™: 円41.77 vs. price of 円24.00 (42.5% below fair value)
No single metric tells the full story. See the TSE:2370 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medinet Co Ltd is a Japan-based Contract Development and Manufacturing Organization (CDMO). The company is engaged in the research and development of regenerative medical products, investigational products, and specified cell products. MEDINET is a one-stop regenerative medicine and cell therapy solution provider. It provides value chain solutions including personnel training, facility and equipment design, facility operations and management, preparation of standard operating procedures, logistics network, information system, purchasing and production management, quality management solutions to medical institutions, research institutions, and biopharmaceutical companies.
45GF Score
Get the complete analysis for TSE:2370
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:2370 has been successfully added to your 
